By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.
By Alexander Bueso
Date: Tuesday 04 Oct 2022
(Sharecast News) - Synairgen announced positive results for its inhaled antiviral protein treatment interferon beta against Covid-19.
By Abigail Townsend
Date: Wednesday 07 Sep 2022
(Sharecast News) - Respiratory drug discovery firm Synairgen has announced positive findings from a clinical trial into its experimental antiviral treatment.
Currency | UK Pounds |
Share Price | 6.49p |
Change Today | -0.100p |
% Change | -1.52 % |
52 Week High | 11.50 |
52 Week Low | 4.88 |
Volume | 203,677 |
Shares Issued | 201.37m |
Market Cap | £13.07m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 20 @ 6.21p |
16:27 | 27 @ 6.21p |
15:37 | 13,560 @ 6.74p |
14:53 | 7,383 @ 6.30p |
14:51 | 917 @ 6.21p |
You are here: research